Jill Clendening Archive — Page 31 of 37
-
August 24, 2017
Benefits of palliative care for liver disease patients studied
Past research has proven that palliative care — specialized medical care focused on pain and symptom management as well as psychosocial interventions to improve quality of life — benefits patients with malignant diseases such as aggressive cancers. Vanderbilt University Medical Center (VUMC) health care providers are now studying whether palliative care can also benefit those with advanced liver disease, a diagnosis that precedes either a life-saving liver transplant or death. -
August 17, 2017
Study questions fees of medical specialty boards
Physicians have been objecting to the high cost of the certification fees of the American Board of Medical Specialties (ABMS) member boards for many years, and a research letter published recently by the Journal of the American Medical Association (JAMA) shows that the revenue of these boards greatly exceeded expenditures in 2013. -
August 10, 2017
Awards honor dedication to excellence
The most recent Credo Award and Five Pillar Leader Award winners were announced at this week’s Clinical Enterprise Leadership Assembly at Langford Auditorium. The awards are conferred on a quarterly basis. -
June 29, 2017
Diabetes education, fun come together at Camp Sugar Falls
In between zip-lining through the woods and playing ball, 13-year-old Rhett Stanley takes a break from summer camp, pulls a tiny bag from his backpack and quickly tests his blood glucose level. Then, just as quickly, he’s back to the fun. -
June 22, 2017
Study uses child’s own immune system against type one diabetes
Eighteen-year-old Grace Long had just been accepted at the renowned United States Naval Academy, with plans to become a nuclear engineering officer. Then, she learned she had type 1 diabetes, an immediate disqualifier for military service. -
June 8, 2017
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).